| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―May―20 |
Comprehensive assessment of pain syndrome and other clinical factors in the development of adverse outcomes in patients with stroke and concomitant COVID-19 |
T.M. Cherenko, Yu.L. Heletiuk, N.S. Turchyna, I.B. Yaroshchuk |
| 2 |
[GO] |
2025―May―20 |
Cytokine profile and proteolytic enzyme levels in plasma of patients with chronic cerebral ischemia following COVID-19 |
V.S. Melnyk, M.O. Mykhailichenko, V.A. Tomchuk, А.S. Huet, T.I. Halenova, N.G. Raksha, et al. (+3) T.B. Vovk, L.I. Kot, O.M. Savchuk |
| 3 |
[GO] |
2025―Apr―24 |
Assessment of hemostatic changes in patients with chronic cerebral ischemia after recovery from COVID-19 |
M.O. Mykhailichenko, V.S. Melnyk, T.I. Halenova, N.G. Raksha, T.B. Vovk, L.I. Kot, et al. (+2) O.O. Savchuk, L.I. Ostapchenko |
| 4 |
[GO] |
2024―Sep―29 |
Proteolytic imbalance in plasma of patients with multiple sclerosis following COVID-19 |
T.I. Halenova, N.G. Raksha, T.B. Vovk, V.L. Karbovskyy, S.M. Sholomon, V.S. Melnyk, et al. (+2) V.A. Tomchuk, O.M. Savchuk |
| 5 |
[GO] |
2024―May―06 |
Characteristics of fibrin/fibrinogen degradation products in multiple sclerosis following SARS-CoV-2 infection |
T.I. Halenova, N.G. Raksha, T.B. Vovk, V.L. Karbovskyy, S.M. Sholomon, V.S. Melnyk, O.M. Savchuk |
| 6 |
[GO] |
2024―Mar―20 |
Analysis of neuropsychological and laboratory parameters in patients with cerebrovascular disease and SARS-CoV-2 compared to those without SARS-CoV-2 |
V.V. Marshtupa, T.I. Nasonova |
| 7 |
[GO] |
2023―Mar―10 |
Клініко-неврологічні та нейропсихологічні характеристики цереброваскулярної патології у пацієнтів, інфікованих SARS-CoV-2, порівняно з групою контролю |
V.V. Marshtupa |
| 8 |
[GO] |
2022―Sep―18 |
COVID-19 і хвороба Паркінсона |
I.M. Karaban, T.V. Hasiuk, N.V. Karasevych |
| 9 |
[GO] |
2022―Mar―13 |
Клінічний досвід застосування комплексного засобу Трилумін при веденні пацієнтів, які перенесли коронавірусну хворобу COVID-19 і мають синдром хронічної втоми на тлі вторинного імунодефіциту |
V.V. Vasylovskyy, A.A. Kosinov, M.V. Golubtsova |
| 10 |
[GO] |
2022―Feb―02 |
Особливості вегетативних розладів у хворих на COVID-19 |
V.A. Vodopianov, O.S. Strelchenko, V.V. Malyshev, M.Yu. Krivonos, M.Yu. Kosse, D.P. Demydenko |
| 11 |
[GO] |
2021―Dec―10 |
Pathogenetic mechanisms of sensorineural hearing loss in patients with COVID-19 and methods for their correction |
M.A. Trishinska, O.Ye. Kononov |
| 12 |
[GO] |
2021―Dec―10 |
Skeletal muscle damage in the course of coronavirus disease (COVID-19) in a pediatric practice. Own supervision: a clinical case |
V.O. Svystilnyk, O.S. Mihnusheva, K.B. Savinova |
| 13 |
[GO] |
2021―Nov―23 |
Neurological disorders in patients who had COVID-19: how to treat during a pandemic |
T.S. Mishchenko, V.M. Mishchenko, V.V. Sokolik, A.V. Fisenko, I.V. Zdesenko |
| 14 |
[GO] |
2021―Oct―13 |
Cognitive impairment in patients with diabetes mellitus in the conditions of COVID-19 |
N.M. Zherdova |
| 15 |
[GO] |
2021―Jun―14 |
Features of cognitive disorders in COVID-19 |
O.O. Kopchak |
| 16 |
[GO] |
2021―May―21 |
Modern aspects of neuropathogenesis and neurological manifestations of COVID-19 |
L.A. Dziak, O.S. Tsurkalenko, K.V. Chekha, V.M. Suk |
| 17 |
[GO] |
2021―May―21 |
Ischemic stroke as a consequence of coagulopathy in coronavirus disease |
H.S. Trepet, L.M. Trepet, Ya.A. Havryliuk |
| 18 |
[GO] |
2021―Apr―19 |
Neuroendocrine disorders in COVID-19 and post-COVID syndrome and their treatment with gamma-aminobutyric acid containing medications (literature review and own data) |
V.M. Pylypenko |
| 19 |
[GO] |
2021―Apr―19 |
Neurological and neuropsychiatric manifestations and complications of SARS-CoV-2 infection: a narrative review and a case presentation in a previously healthy young white adult |
O.Yе. Fartushna, H.V. Palahuta, S.K. Yevtushenko |
| 20 |
[GO] |
2020―Dec―29 |
A case of acute myelitis as a neurological complication of COVID-19 |
H.V. Palahuta, S.K. Yevtushenko |
| 21 |
[GO] |
2020―Dec―29 |
Pathogenetically substantiated prevention of cerebrovascular disorders in patients with coronavirus disease |
M.A. Treshchinskaia, O.Ye. Kononov, I.V. Belskaia |
